Summary by Moomoo AI
Hualien Pharmaceutical-B (2552) announces that a Board meeting will be held on March 28, 2024 to consider and approve matters including the 2023 Annual Results Report and the Final Dividend Proposal. The meeting will be hosted by Dr. Chen Li, Chief Executive Officer and Executive Director, and will address other relevant matters. This announcement was made by the Company on 18 March 2024 in Hong Kong.